INTERNATIONAL PATENT: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD., 长春金赛药业有限责任公司 FILES APPLICATION FOR "FC FUSION PROTEIN WHICH BLOCKS ACTION OF BAFF AND APRIL ON RECEPTORS THEREOF"

GENEVA, March 29 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2025/122645) for "FC FUSION PROTEIN WHICH BLOCKS ACTION OF BAFF AND APRIL ON RECEPTORS THEREOF" on Sep 19, 2025. With publication no. WO/2026/061495, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed b...